Full View

Impact of sirolimus as a primary immunosuppressant on myocardial fibrosis and diastolic function following heart transplantation

H Alnsasra, R Asleh, JK Oh… - Journal of the …, 2021 - Am Heart Assoc
Background Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …
被引用次数：13 相关文章

THE IMPACT OF SIROLIMUS AS A PRIMARY IMMUNOSUPPRESSANT ON MYOCARDIAL FIBROSIS AND DIASTOLIC FUNCTION FOLLOWING HEART …

H Alnsasra, R Asleh, J Oh, J Maleszewski… - Journal of the American …, 2021 - jacc.org
Background Myocardial fibrosis is an important contributor for development of diastolic
dysfunction (DD). We investigated the impact of sirolimus (SRL) as primary …

The Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation

H Alnsasra, R Asleh, JK Oh, JJ Maleszewski… - The Journal of Heart and …, 2021 - Elsevier
Purpose Myocardial fibrosis is an important contributor for development of diastolic
dysfunction (DD) following heart transplantation (HT). Small studies have reported …
[HTML] nih.gov

[HTML][HTML] Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation

H Alnsasra, R Asleh, JK Oh… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Background Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …

Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation.

H Alnsasra, R Asleh, JK Oh… - Journal of the …, 2020 - europepmc.org
Background Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …

Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation

H Alnsasra, R Asleh, JK Oh… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …

The Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation

H Alnsasra, R Asleh, JK Oh, JJ Maleszewski… - The Journal of Heart …, 2021 - jhltonline.org
Purpose Myocardial fibrosis is an important contributor for development of diastolic
dysfunction (DD) following heart transplantation (HT). Small studies have reported …

Impact of sirolimus as a primary immunosuppressant on myocardial fibrosis and diastolic function following heart transplantation

H Alnsasra, R Asleh, JK Oh… - Journal of the …, 2021 - mayoclinic.elsevierpure.com
BACKGROUND: Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …
[PDF] researchgate.net

[PDF][PDF] Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation

H Alnsasra, R Asleh, JK Oh, JJ Maleszewski, A Lerman… - 2020 - researchgate.net
BACKGROUND: Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …

Impact of sirolimus as a primary immunosuppressant on myocardial fibrosis and diastolic function following heart transplantation

H Alnsasra, R Asleh, JK Oh, JJ Maleszewski… - Journal of the …, 2021 - cris.bgu.ac.il
BACKGROUND: Myocardial fibrosis is an important contributor for development of diastolic
dysfunction. We investigated the impact of sirolimus as primary immunosuppression on …